Luteinizing hormone

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Luteinizing hormone
Accession Number
DB14741
Description
Not Available
Type
Biotech
Groups
Approved
Biologic Classification
Protein Based Therapies
Hormones
Protein Chemical Formula
Not Available
Protein Average Weight
Not Available
Sequences
Not Available
Synonyms
  • Gonadotropin, luteinizing hormone
  • LH
  • Luteinising hormone
  • Luteinising hormone (human)
  • Luteinizing gonadotropic hormone
  • Luteinizing hormone
  • Luteotropic hormone
  • Pituitary luteinizing hormone

Pharmacology

Indication
Not Available
Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Purchasing individual compounds or compound libraries for your research?
Learn More
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Humegon Inj 75 I.U.Luteinizing hormone (75 unit) + Follitropin (75 unit) + Sodium chloride (.9 %)Liquid; Powder, for solutionIntramuscularOrganon Canada Ltd Ltee1993-12-312006-08-17Canada flag
MenopurLuteinizing hormone (75 [iU]/1mL) + Follitropin (75 [iU]/1mL) + Sodium chloride (9 mg/1mL)SubcutaneousFerring Pharmaceuticals Inc.2004-10-29Not applicableUS flag
Pergonal 75 I.U.Luteinizing hormone (75 unit) + Follitropin (75 unit)Powder, for solutionIntramuscularEmd Serono, A Division Of Emd Inc., Canada1979-12-312007-05-07Canada flag
RepronexLuteinizing hormone (75 [iU]/2mL) + Follitropin (75 [iU]/2mL)KitIntramuscular; SubcutaneousFerring Pharmaceuticals1999-08-272014-12-31US flag

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
Not Available
Kingdom
Organic Compounds
Super Class
Organic Acids
Class
Carboxylic Acids and Derivatives
Sub Class
Amino Acids, Peptides, and Analogues
Direct Parent
Peptides
Alternative Parents
Not Available
Substituents
Not Available
Molecular Framework
Not Available
External Descriptors
Not Available

Chemical Identifiers

UNII
8XA4VN1LH4
CAS number
9002-67-9

References

General References
Not Available
RxNav
6383
Wikipedia
Luteinizing_hormone

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4CompletedBasic ScienceControlled Ovarian Stimulation / Infertility1
4CompletedOtherCardiovascular Heart Disease / Prostatic Neoplasms1
4CompletedTreatmentAssisted Reproductive Technology therapy / Infertility1
4CompletedTreatmentPregnancy1
4Not Yet RecruitingTreatmentFemale Infertility1
4TerminatedTreatmentIdiopathic Hypogonadotropic Hypogonadism1
4Unknown StatusTreatmentInfertility1
3Active Not RecruitingTreatmentProstate Cancer1
3CompletedTreatmentHypogonadism1
3CompletedTreatmentInfertility / Ovarian Stimulation1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Liquid; powder, for solutionIntramuscular
Injection, powder, lyophilized, for solutionIntramuscular; Subcutaneous75 iu
Injection, powder, for solutionIntramuscular; Subcutaneous75 IU
Injection, powder, lyophilized, for solutionSubcutaneous1200 iu/1ml
Injection, powder, lyophilized, for solutionIntramuscular; Subcutaneous150 iu
Injection, powder, lyophilized, for solutionSubcutaneous600 iu/1ml
Powder, for solutionIntramuscular
KitIntramuscular; Subcutaneous
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created on February 27, 2019 16:25 / Updated on June 12, 2020 10:53

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates